Maze Therapeutics director Scheller sells $464k in shares
NegativeFinancial Markets

Maze Therapeutics director Scheller has sold $464,000 worth of shares, raising concerns among investors about potential insider knowledge or lack of confidence in the company's future. Such sales can often signal troubling times ahead for a company, leading to speculation and uncertainty in the market. It's crucial for stakeholders to monitor these developments closely as they could impact the company's stock performance.
— Curated by the World Pulse Now AI Editorial System